- Filed
- Jul 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Jul 15, 2024 | 53.2M sh |
| Short Term Investments | Q3 2024 · May 31, 2024 | $4M |
| Short Term Investments | Q3 2024 · Aug 31, 2023 | $5.5M |
| Current Liabilities | Q3 2024 · May 31, 2024 | $359.41K |
| Current Liabilities | Q3 2024 · Aug 31, 2023 | $287.23K |
| Total Liabilities | Q3 2024 · May 31, 2024 | $359.41K |
| Total Liabilities | Q3 2024 · Aug 31, 2023 | $287.23K |
| Current Assets | Q3 2024 · May 31, 2024 | $5.62M |
| Current Assets | Q3 2024 · Aug 31, 2023 | $6.3M |
| Total Assets | Q3 2024 · May 31, 2024 | $5.64M |
| Total Assets | Q3 2024 · Aug 31, 2023 | $7.62M |
| Revenue | Q3 2024 · May 31, 2024 | $0 |
| Revenue | Q3 2024 · May 31, 2024 | $0 |
| Revenue | Q3 2024 · May 31, 2023 | $0 |
| Revenue | Q3 2024 · May 31, 2023 | $0 |
| Shares Diluted | Q3 2024 · May 31, 2023 | 53.2M sh |
| Shares Diluted | Q3 2024 · May 31, 2023 | 53.2M sh |
| Operating Cash Flow | Q3 2024 · May 31, 2023 | −$1.58M |
| Stockholders Equity | Q3 2024 · May 31, 2023 | $7.9M |
| Stockholders Equity | Q3 2024 · Feb 28, 2023 | $8.43M |
| Stockholders Equity | Q3 2024 · Nov 30, 2022 | $8.93M |
| Stockholders Equity | Q3 2024 · Aug 31, 2022 | $9.57M |
| Eps Diluted | Q3 2024 · May 31, 2023 | −$0.01 |
| Eps Diluted restated | Q3 2024 · May 31, 2023 | −$0.03 |
| Eps Basic | Q3 2024 · May 31, 2023 | −$0.01 |
| Eps Basic restated | Q3 2024 · May 31, 2023 | −$0.03 |
| Sga Expense | Q3 2024 · May 31, 2023 | $383.23K |
| Sga Expense | Q3 2024 · May 31, 2023 | $1.13M |
| Rd Expense | Q3 2024 · May 31, 2023 | $195.46K |
| Rd Expense | Q3 2024 · May 31, 2023 | $592.33K |
| Operating Income | Q3 2024 · May 31, 2023 | −$578.69K |
| Operating Income | Q3 2024 · May 31, 2023 | −$1.72M |